Related Experiment Video
Updated: May 9, 2026

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
In vitro activity of selected antimicrobials against methicillin-resistant Staphylococcus pseudintermedius of canine
Magdalena Kizerwetter-Świda1, Dorota Chrobak-Chmiel1, Ilona Stefańska1
1Department of Preclinical Sciences, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Warsaw, Poland.
Background:
Methicillin-resistant Staphylococcus pseudintermedius (MRSP) is an important veterinary pathogen. In general, only a few antimicrobials show in vitro activity against MRSP isolates.
Objectives:
The objective of this study was to determine the in vitro activity of selected antimicrobials, including last-choice drugs, against clinical MRSP isolates of canine origin. The activity of 10 selected agents was evaluated against 41 clinical MRSP isolates.
Methods:
The disk diffusion method and minimal inhibitory concentration values were used for antimicrobial susceptibility testing (AST). The guidelines for staphylococci of canine or human origin were employed for the interpretation of the results.
Results:
Among the examined MRSP isolates, resistance to enrofloxacin and clindamycin was the most prevalent (n = 40; 97.6%). Resistance to doxycycline and gentamicin was observed in 83.0% (n = 34) and 68.3% (n = 28) of the isolates, respectively. Single isolates were resistant to chloramphenicol (n = 5; 12.2%) and rifampicin (n = 3; 7.3%), whereas all showed susceptibility to amikacin, vancomycin, mupirocin and linezolid. Predominantly, the results of AST obtained by both methods were consistent. Some discrepancies were observed for gentamicin; however, clinical breakpoints for staphylococci of human origin were used.
Conclusions:
Amikacin and chloramphenicol constitute potential treatment options in infections caused by MRSP and may be included in extended susceptibility testing in our geographical region. The determination of clinical breakpoints for some antimicrobials not incorporated in the recommendations should be a high priority in the veterinary diagnostics.
Insights
Methicillin-resistant Staphylococcus pseudintermedius (MRSP) in dogs shows high resistance to common antibiotics. Amikacin and vancomycin remain effective, offering potential treatment options for MRSP infections.
Area of Science:
- Veterinary Microbiology
- Antimicrobial Resistance
- Companion Animal Health
Background:
- Methicillin-resistant Staphylococcus pseudintermedius (MRSP) is a significant veterinary pathogen.
- Limited antimicrobial options are typically effective against MRSP isolates.
- Canine MRSP infections pose a growing clinical challenge.
Purpose of the Study:
- To evaluate the in vitro activity of selected antimicrobials against clinical MRSP isolates from dogs.
- To assess the efficacy of last-choice drugs against canine MRSP.
- To identify potential therapeutic agents for MRSP infections in companion animals.
Main Methods:
- Antimicrobial susceptibility testing (AST) was performed on 41 clinical MRSP isolates.
- Disk diffusion and minimal inhibitory concentration (MIC) methods were utilized.
- Guidelines for staphylococci of canine or human origin were applied for interpretation.
Main Results:
- High prevalence of resistance was observed for enrofloxacin (97.6%) and clindamycin (97.6%).
- Resistance to doxycycline (83.0%) and gentamicin (68.3%) was also common.
- All isolates remained susceptible to amikacin, vancomycin, mupirocin, and linezolid.
Conclusions:
- Amikacin and vancomycin are potential treatment options for MRSP infections in dogs.
- Extended susceptibility testing for agents like amikacin and chloramphenicol is recommended.
- Establishing clinical breakpoints for veterinary-specific antimicrobials is crucial for diagnostics.
More Related Videos
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
06:18A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
Published on: March 3, 2023
Related Concept Videos
Antibiotic Selection
Antimicrobial Effectiveness
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance